News
For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...
Elon Musk is President Trump’s “seriously overweight” friend who takes “the fat shot,” according to the Tesla CEO’s own artificial intelligence bot. Trump was discussing plans to lower medication ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...
4h
Best Life on MSNWeight-Loss Drugs Could Slash Cancer Risk by 41%—Here’s Who BenefitsParticipants in a new study who used GLP-1 drugs had a much lower cancer risk than those who had bariatric surgery.
IT ONCE boasted over five million subscribers and saw one million of us stepping onto the scales every year. But Weight ...
Ozempic's double-sided coin: Amid skyrocketing popularity of GLP-1 drugs, a burgeoning lawsuit looms
Ozempic was originally approved by the Food and Drug Administration (FDA) to treat people with Type 2 diabetes, who risk ...
President Trump shared a story about a businessman friend's frustration with the high cost of a weight-loss drug in the U.S.
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
New research has shown that Ozempic can cause taste changes in people taking it, even going so far as to make some hate the ...
The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...
Experts say weight management drugs have created an unsustainable surge in health care spending, with some insurance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results